BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

802 related articles for article (PubMed ID: 27083427)

  • 1. Status of paratyphoid fever vaccine research and development.
    Martin LB; Simon R; MacLennan CA; Tennant SM; Sahastrabuddhe S; Khan MI
    Vaccine; 2016 Jun; 34(26):2900-2902. PubMed ID: 27083427
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vi Capsular Polysaccharide Produced by Recombinant
    Xiong K; Zhu C; Chen Z; Zheng C; Tan Y; Rao X; Cong Y
    Front Cell Infect Microbiol; 2017; 7():135. PubMed ID: 28484685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cross-reactive gut-directed immune response against Salmonella enterica serovar Paratyphi A and B in typhoid fever and after oral Ty21a typhoid vaccination.
    Pakkanen SH; Kantele JM; Kantele A
    Vaccine; 2012 Sep; 30(42):6047-53. PubMed ID: 22858557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improving Our Understanding of
    Higginson EE; Ramachandran G; Hazen TH; Kania DA; Rasko DA; Pasetti MF; Levine MM; Tennant SM
    mSphere; 2018 Nov; 3(6):. PubMed ID: 30487152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaccine value profile for Salmonella enterica serovar Paratyphi A.
    Martin LB; Khanam F; Qadri F; Khalil I; Sikorski MJ; Baker S
    Vaccine; 2023 Nov; 41 Suppl 2():S114-S133. PubMed ID: 37951691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enteric fever and its impact on returning travellers.
    Dave J; Sefton A
    Int Health; 2015 May; 7(3):163-8. PubMed ID: 25808163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and immunogenicity evaluation of Salmonella enterica serovar Paratyphi A O-specific polysaccharide conjugated to diphtheria toxoid.
    Ali A; An SJ; Cui C; Haque A; Carbis R
    Hum Vaccin Immunother; 2014; 10(6):1494-8. PubMed ID: 24603090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Attenuated
    Liu Q; Li P; Luo H; Curtiss R; Kong Q
    Virulence; 2019 Dec; 10(1):82-96. PubMed ID: 31874075
    [No Abstract]   [Full Text] [Related]  

  • 9. Construction of an attenuated Salmonella enterica serovar Paratyphi A vaccine strain harboring defined mutations in htrA and yncD.
    Zhu C; Xiong K; Chen Z; Hu X; Li J; Wang Y; Rao X; Cong Y
    Microbiol Immunol; 2015 Aug; 59(8):443-51. PubMed ID: 26084199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and immunogenicity of an attenuated Salmonella enterica serovar Paratyphi A vaccine candidate.
    Xiong K; Chen Z; Zhu C; Li J; Hu X; Rao X; Cong Y
    Int J Med Microbiol; 2015 Sep; 305(6):563-71. PubMed ID: 26239100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaccines against typhoid fever.
    Guzman CA; Borsutzky S; Griot-Wenk M; Metcalfe IC; Pearman J; Collioud A; Favre D; Dietrich G
    Vaccine; 2006 May; 24(18):3804-11. PubMed ID: 16278037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ty21a live oral typhoid vaccine and prevention of paratyphoid fever caused by Salmonella enterica Serovar Paratyphi B.
    Levine MM; Ferreccio C; Black RE; Lagos R; San Martin O; Blackwelder WC
    Clin Infect Dis; 2007 Jul; 45 Suppl 1():S24-8. PubMed ID: 17582564
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increasing rates of Salmonella Paratyphi A and the current status of its vaccine development.
    Sahastrabuddhe S; Carbis R; Wierzba TF; Ochiai RL
    Expert Rev Vaccines; 2013 Sep; 12(9):1021-31. PubMed ID: 24053396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. O:2-CRM(197) conjugates against Salmonella Paratyphi A.
    Micoli F; Rondini S; Gavini M; Lanzilao L; Medaglini D; Saul A; Martin LB
    PLoS One; 2012; 7(11):e47039. PubMed ID: 23144798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunization with Ty21a live oral typhoid vaccine elicits crossreactive multifunctional CD8+ T-cell responses against Salmonella enterica serovar Typhi, S. Paratyphi A, and S. Paratyphi B in humans.
    Wahid R; Fresnay S; Levine MM; Sztein MB
    Mucosal Immunol; 2015 Nov; 8(6):1349-59. PubMed ID: 25872480
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Salmonella Typhi outer membrane protein STIV is a potential candidate for vaccine development against typhoid and paratyphoid fever.
    Das S; Chowdhury R; Pal A; Okamoto K; Das S
    Immunobiology; 2019 May; 224(3):371-382. PubMed ID: 30952553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Typhoid and paratyphoid fever].
    Trawinski H; Wendt S; Lippmann N; Heinitz S; von Braun A; Lübbert C
    Z Gastroenterol; 2020 Feb; 58(2):160-170. PubMed ID: 32050286
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Impact of Vaccination and Prior Exposure on Stool Shedding of Salmonella Typhi and Salmonella Paratyphi in 6 Controlled Human Infection Studies.
    Gibani MM; Voysey M; Jin C; Jones C; Thomaides-Brears H; Jones E; Baker P; Morgan M; Simmons A; Gordon MA; Cerundolo V; Pitzer VE; Angus B; Levine MM; Darton TC; Pollard AJ
    Clin Infect Dis; 2019 Apr; 68(8):1265-1273. PubMed ID: 30252031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Specific and cross-reactive immune response to oral Salmonella Typhi Ty21a and parenteral Vi capsular polysaccharide typhoid vaccines administered concomitantly.
    Pakkanen SH; Kantele JM; Savolainen LE; Rombo L; Kantele A
    Vaccine; 2015 Jan; 33(3):451-8. PubMed ID: 25433216
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Typhoid and paratyphoid fever: a clinical seminar.
    Manesh A; Meltzer E; Jin C; Britto C; Deodhar D; Radha S; Schwartz E; Rupali P
    J Travel Med; 2021 Apr; 28(3):. PubMed ID: 33550411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 41.